Trevi Therapeutics

TRVINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.628 B

$18.51 +0.05%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$42.8M

Loss-making

Shares outstanding

142,475,841

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#85AtaiBeckleyATAI$2.67B
#86Nurix TherapeuticsNRIX$2.65B
#87Trevi TherapeuticsTRVI$2.63B
#88Zai LabZLAB$2.62B
#89Prestige Consumer HealthcarePBH$2.60B

Where these numbers come from

Share counts and financials for Trevi Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.